In the multivariable analysis, male sex (OR: 2.397, 95% CI: 1.069–5.375, p = 0.034), CLD (OR: 7.180, 95% CI: 1.317–39.134, p = 0.023), preoperative symptoms (OR: 4.481, 95% CI: 1.879–10.689, p < 0.001), elevated CEA (> 2.5 ng/mL) (OR: 2.431, 95% CI: 1.067–5.541, p = 0.035), sarcopenic obesity (OR: 2.366, 95% CI: 1.038–5.395, p = 0.041), clinically T3 or higher stage (OR: 12.375, 95% CI: 2.728–56.130, p = 0.001), and clinically suspicious lymph node metastasis (OR: 8.924, 95% CI: 3.375–23.597, p < 0.001) were significantly associated with early recurrence. This evidence concerns the gene CEACAM5 and metastatic malignant neoplasm in the lymph nodes.